Evidence map›Paper›PMID 30925656›Full record

ArticleJournal of clinical medicine2019

Human Diseased Articular Cartilage Contains a Mesenchymal Stem Cell-Like Population of Chondroprogenitors with Strong Immunomodulatory Responses.

Paola De Luca, Dimitrios Kouroupis, Marco Viganò, Carlotta Perucca-Orfei, Lee Kaplan, Luigi Zagra, Laura de Girolamo, Diego Correa, Alessandra Colombini

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Paola De LucaIRCCS Istituto Ortopedico Galeazzi, Orthopaedic Biotechnology Lab, Milan 20161, Italy. deluca.paola@grupposandonato.it.
Dimitrios KouroupisDepartment of Orthopedics, UHealth Sports Medicine Institute, University of Miami, Miller School of Medicine, Miami, FL 33146, USA. dxk504@med.miami.edu.
Marco ViganòIRCCS Istituto Ortopedico Galeazzi, Orthopaedic Biotechnology Lab, Milan 20161, Italy. marco.vigano@grupposandonato.it.ORCID 0000-0002-6463-6564
Carlotta Perucca-OrfeiIRCCS Istituto Ortopedico Galeazzi, Orthopaedic Biotechnology Lab, Milan 20161, Italy. carlotta.perucca@grupposandonato.it.
Lee KaplanDepartment of Orthopedics, UHealth Sports Medicine Institute, University of Miami, Miller School of Medicine, Miami, FL 33146, USA. kaplan@med.miami.edu.
Luigi ZagraIRCCS Istituto Ortopedico Galeazzi, Hip Department, Milan 20161, Italy. luigi.zagra@fastwebnet.it.
Laura de GirolamoIRCCS Istituto Ortopedico Galeazzi, Orthopaedic Biotechnology Lab, Milan 20161, Italy. laura.degirolamo@grupposandonato.it.
Diego CorreaDepartment of Orthopedics, UHealth Sports Medicine Institute, University of Miami, Miller School of Medicine, Miami, FL 33146, USA. dxc821@med.miami.edu.
Alessandra ColombiniIRCCS Istituto Ortopedico Galeazzi, Orthopaedic Biotechnology Lab, Milan 20161, Italy. alessandra.colombini@grupposandonato.it.ORCID 0000-0002-1800-3424
Istituto Ortopedico Galeazzi · ITUniversity of Miami · USUniversity of Miami Health System · US

Funding

Ministero della Salute Valutazione del potenziale utilizzo del secretoma concentrato ottenuto da cellule staminali mesenchimali isolate da tessuto adiposo per il trattamento dell'osteoartrosi e della degenerazione tendineaSoffer Family Foundation Stem Cell Treatments in Sports Medicine
6 · The paper itself

Abstract

backgroundosteoarthritic human articular cartilage (AC)-derived cartilage cells (CCs) with same-donor bone marrow (BMSCs) and adipose tissue (ASCs)-derived mesenchymal stem cells were compared, in terms of stemness features, and secretory and immunomodulatory responses to inflammation.

methodsproteoglycan 4 (PRG4) presence was evaluated in AC and CCs. MSCs and CCs (

resultsPRG4 was mainly expressed in the intact AC surface, whereas shifted to the intermediate zone in damaged cartilage and increased its expression in CCs upon culture. All cells exhibited a similar phenotype and stemness maintenance over passages. CCs showed highest chondrogenic ability, no adipogenic potential, a superior basal secretion of growth factors and cytokines, the latter further increased after inflammatory stimulation, and an immunomodulatory behavior. All stimulated cells shared an increased MMP expression without a corresponding TIMP production.

conclusionbased on the observed features, CCs obtained from pathological joints may constitute a potential tissue-specific therapeutic target or agent to improve damaged cartilage healing, especially damage caused by inflammatory/immune mediated conditions.

Indexed as

cartilage cellscartilage-derived stem/progenitor cellsimmunomodulationinflammationmesenchymal stem cellssecretomestemness

Identifiers

PMID30925656
PMCPMC6517884
OpenAlexW2923873005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.